PRE-FILED,

PRE-NUMBERED

EXHIBIT

COVER SHEET |

Exhibit CY-5-

PANEL1-.

For Reporters' Use Only

United States of America

Nuclear Regulatory Commission

before the

Atomic Safety and Licensing Board

In the Matter of

Docket No. 50-213-LTP

CONNECTICUT YANKEE AToNSC POWER COMSPANY

N c ASLBP No. 01-787-02-OLA

(Haddaxn Neck Plant)

PANEL ATrACHMENT 4: "HEALTH PHYSICS DEPARTMENT, TECHNICAL SUPPORT

DOCUMENT, HP NUMBER: BCY-HP-0125 REV. 0: DOSE ESTIMATE FOR AN

INGESTED PARTICLE" (12/05/02).

Submitted by:

R. K. Gad II

Martin J. Newhouse

Ropes & Gray

One International Place

Boston, MA 02110

Counsel to CY

Dated: February 7, 2003.

5/q
BCY-HP-0125 Revision 0

Page I of 18

UNCONTROLLED

COPY

BECHTEL HEALTH PHYSICS

TECHNICAL SUPPORT DOCUMENT

DOCUMENT No.

24265-000-G65-GEHH-P0125-000

Connecticut Yankee Decommissioning

Health Physics Department Technical Support

Document

HP Number: BCY-BHP-0125 Revsion#: 0

Subject: Dose Estimate for an Ingested Particle

Date: 12105/02

'1114" /,//,. /,J Date:

Date:

Date:

I /-I

2//a / ao.

I I I :
BCY-HP-0125 Revision 0

Page 2 of 18

PURPOSE

To provide a dose estimate from the ingestion of a 1 j±Ci particle.

DISCUSSION

Assumptions and Basis

This assessment was performed using the following assumptions:

1. The particle is insoluble and therefore does not enter the blood stream but rather passes

through the gastrointestinal (GI) tract, similar to a bolus of material.

2. The ingestion pathway is the only pathway considered since a hot particle is likely to exceed

10 micron activity median aerodynamic diameter (AMAD).

3. The only progeny nuclide included in this assessment is Y-90 (Sr-90 progeny) because its

half life is short enough to result in secular equilibrium. The remaining nuclides half lives

are too long to reach secular equilibrium.

The number of disintegrations for each segment of the GI tract for each nuclide in the License

Termination Plan (LTP) in Table 2-12, Radionuclides Potentially Present at HNP, was determined by

using INDOS0. Even though the particle is expected to be eliminated within 42 hours (based upon the

sum of the mean residence times for each of the organs along the GI tract), the total number of

disintegrations calculated over 50 years was used for conservatism. The input parameters used are

illustrated in Table 1. The number of disintegrations for each segment of the GI tract is listed in Table

2 for a 1 Bq activity of each radionuclide. Note that the number of disintegrations for each segment of

the GI tract for each nuclide is essentially the same. The reason for this is that the half-lives of the

radionuclides in the LTP are long compared to the passage time through the GI tract. Therefore, the

number of disintegrations is determined primarily by the clearance fine assumed, as stated previously,

for conservatism the total number of disintegrations over 50 years was used. A copy of the INDOS

runs for the shortest half-life nuclide and longest half-life nuclide in the LTP is included as Attachment

1.
BCY-H.PI1-5 Revision 0

Page 3 of 18

Table 1. INDOS Input Parameters and Values

Parameter Value Comment

fl 0 Zero value assumes particle is insoluble

Intake Pathway Ingestion Only considered pathway

Exposure Condition Acute Appropriate for particle ingestion.

Systemic NOS requires at least one systemic

Compartments compartment.

Compartment half life was deliberately

set low, since this assessment only

Systemic Half Life 2.OOE-06 Days evaluates the dose to the GI tract.

Therefore, this parameter does not effect

the dose to the GI tract

Since the particle is considered to be

Fraction of Systemic 0 representative of a bolus (i.e., insoluble),

Excreted through urine the particle will travel through the GI and

be eliminated through feces.

Since the particle is considered to be

Fraction of Systemic 1 representative of a bolus (i.e., insoluble),

Excreted through feces the particle will travel through the GI and

be eliminated through feces.

Time post intake days INDOS calculates the number of

(T) disintegrations post intake between time,

T1 and T2. Setting T1 to 0 and T2 to

1.75 days gives the total # of

Time post intake days disintegrations that occur while the

(1p).75 particle passes through the body.

However, the fifty year value was used in

this assessment for the estimate of CEDE.

I~~ .
BCY-HP-0125 Revision 0

Page 4 of 18

Table 2. Number of Disintegrations for each Segment of the GI Tract for an Intake Activity of 1 Bq.

T1 T2 DIstint. # Dlstint.

Post Post Upper #1Distint. Lower

Half-LIfe Intake Intake Intake # DlstInt. Large Small Large # Distint.

Nucllde (days) pathway jqffs (days( Stomach IntestIne Intestine Intestine GI Total

Aa-1 O8m .64E+04 Ingestion 0 182503.60E+03 4.68E+O4I .44E+04 8.64E+041.51E+05

Am-241 1 .58E+05 Ingestion 0 182503.60E+03 4.68E+04 .4412+04 .64E+041 .51E+05

C-124 .09E+06 Ingestion 0 18250 3.60E+0 4.68E+O 1.44E+04 8.64E+04 1.51E+05

Co-243 1 .04E+04 Ingestion 0 182503.60E+03 4.88E+04 1 .44E+04 8.64E+04 1.51 E+05

Co-13 1.92E+03 Ingestion 0 18250 3.60E+03 .68E+04 i .44E+04 8.64E+04 1.51 E+05

Cs-134 7.53E+02 Ingestion 0 18250 3.60E+03 4.68E+04 1.44E+0A 8.63E+04 1.51 E+05

Cs-i 37 1.1 0OE+04 Ingestion 0 18250 3.60E+03 4.68E+04 1 .44E0 8.64E+D4 1.51 E+05

Eu-1 52 3.21E+03 Ingestion 0 18250 3.60E+03 4.682+04 1.44E+04 8.64E+04 1.51 E+05

Eu-1 54 21 E+03 Ingestion 0 18250 3.60E+03 4.68E+04 1 .44E+04 8.64E+04 1.51 E+05

Eu-1 55 1 .81E+03 Ingestion 0 18250 .60E+03 .682+04 1.44E+04 8.64E+04 1.51 2+05

Fe-55 4.8E+02 Ingestion 0 18250 3.60E+03 6sE+04 1 .44E+04 8.64E+04 1.51E+05

H-3 .492+03 Ingestion 0 18250 3.60E+03 .68E+04 1.44E+04 8.64E+04 1.51 E+.5

Mn-54 3.12E+02 Ingestion 0 18250 3.BOE+03 .67E+04 1.44E+04 8.61 E+04 1.51 E+0I5

Nb-94 7.30E+06 Inqgestfon 0 18250 .BOE+03 .68E+04 1.44E+04 8.64E+04 1.51 E+05

NI-63 3.65E+04 Ingestion 0 18250 3.60E+03 .68E+04 1.44E+04 8.64E+04 1.51 E+05

Pu-238 320E+04 Ingestion 0 18250 .60E2+3 4.8E+0 1.44E+04 .64E+04 1 .1 E+05

Pu-239 8.80E+06 Ingestion 0 18250 a60E+03 4.68E+04 1.44E+04 8.64E+04 1.51 E+05

Pu-241 S.26E+03 Ingestlon 0 18250 60+03 4.68E+04 1 A4E+04 .64E+04 1.51 E+05

Sr-90 1.04E+0 Ingeston 0 18250 .60E+03 4.68E+041.44E+04 8.64E+04 1.51E+05

Tc-99 7.772+07 Ingeston 0 18250 3.60E+03 1.GE+04 1.44E+04 8.64E+04 1.51 E+05

Organ Dose

The Specific Effective Energy (SEE) terms were used from ICRP-30 (Reference 1) to determine the

dose to other target organs from the disintegrations in the GI tract. Attachments 2 through 5 list the

specific absorbed dose factors (Mev per gram per Becquerel) for each organ and each nuclide in the

LTP for the small intestine (SI), upper large intestine (Il), lower large intestine (LL1), and stomach,

respectively. Table 3 lists the sum of the specific absorbed dose factors (Mev per gram per Becquerel)

for each of the GI tract components, which is converted to dose equivalent factor (rem per bequerel) by

multiplying by the conversion factor provided in ICRP 30 of 1.6E-10 Sievert (Sv) per MeV per gram

and 100 to convert Sv to rem.

It should be noted that the SEE Values in ICRP 30 assume instantaneous uniform mixing of the

radionuclide within the compartment (organ). This actually overestimates the dose, since this

evaluation is for a discrete particle (i.e., uniform mixing will not occur) and uniform irradiation of the

compartment (organ) will not occur. This represents a significant overestimate of dose for alpha

emitting nuclides since most of the alpha energy is absorbed in the GI tract content. This is evident in

Table 3 since the alpha transuranics illustrate a substantially higher dose than other beta/gamma
BCY.HP-0125 Revision 0

Page 5 of 18

emitting nuclides. However, no adjustments are made in this assessment to account for these

conservative assumptions.

Table 3. Absorbed Dose and Dose Equivalent Factors for LUP nuclides

Dose

Absorbed Dose Equlvalen

Factor Factor

Nucilde (Maovgramlbg) (Remibq)

Ag-1o8m 2.39E+01 3.82E-07

An-241 o.0OE+00 O.OOE+OO

C-14 O.OOE+00 0.OOE+00

Cm-243 O.OE+00 0.00E+00

Co-6O 1.18E+01 1.88E-07

Cs-134 O.OOE+00 0.00E+00

Cs-137 O.OOE+0 O.OOE+00

Eu-162 8.30E+00 1.33E-07

Eu-154 124E+01 1.99E-07

Eu-155 1.94E+00 3.11 E-08

Fe-55 1.1 8E-01 1.88E-09

H-3 O.OOE+00 O.OOE+00

Mne-4 a58E+OO 5.75E.08

Nb-94 7.92E+00 1.2E-07

NM63 4.61 E-01 7.39E-09

Pu-238 2.83E+01 4.53E-07

Pu-239 2.61 E+O1 4.19E-07

PU-241 9.84E-02 1.58E-09

Sr.90 2.90E+01 4.65E-07

Tc-99 3.21 E+00 5.14E-08

Total 1.57E+0a 2.52E-06

I

I

i

Determination of Nucide Scaling

Nuclide scaling was performed using the same conservative waste stream mixture used in calculating

annual doses from contaminated embedded piping as described in the LTP (reference 2). The sample

was a composite of Dry Activated Waste (DAW) in the WDB from 2000. This sample was shipped off

site and analyzed by Duke Engineering and Services Environmental Laboratory (DES). The analysis

results are provided in Attachment 6. A summary of the results for the nuclides in the LTP is provided

in Table 4. The activity results were used to scale the dose in order to determine the dose relative to the

worst case expected radionuclide mix. A nuclide fracdon was determined by dividing each individual

nuclide activity by the total activity in the sample. If the nuclide activity did not exceed the Minimum

Detectable Activity (MDA) of the sample, than the reported MDA was used as the activity amnount.

The sarnple was analyzed on December 6, 2000. Therefore the nuclides were decay corrected to
BCY-HP.0125 Revision 0

Page 6 of 18

determine the scaling fraction. Europium-152, Euriopium-154, and Europium-155 were not listed in

the Part 61 analysis provided by DES.

Table 4. Part 61 Results of Composite Sample of DAW from WDB In 2000

Decayed Ncde Acivite Nucdide Activity Decay Corrected

Nule uCtivityle Fraction (uCi/sample) Nuclide Fraction

H-3 1.50E-03 Reported MDA 2.73E-02 1.35E-03 2.67E-02

C-14 1.80E-03 Reported MDA 3.27E-02 1.80E-03 3.55E-02

Mn-54 4.70E-04 Reported MDA 8.54E-03 1.07E}04 2.11E-03

Fe-55 7.30E-04 Reported A 1.33E-02 4.57E-04 9.01E-03

Co-60 1.52E-03 2.76E-02 1.20E-03 236E-02

Ni-63 3.45E.03 . 6.27E-02 3.41E-03 6.72E-02

Sr-90 2.09E-03 3.80E-02 2.0OE-03 3.94E-02

Nb-94 4.60E-04 Reported MDA 836E-03 4.60E-04 9.07E-03

Tc-99 6.10E-03 Reported MDA 1.1 1E-01 6.10E-03 1.20E-01

Ag-108m 5.30E-04 Reported MDA 9.63E-03 5.25E-04 1.03E-02

Eu-152 Not Provided O.OOE+00 N/A N/A

Eu-154Not Provided O.OOE+00 NIA N/A

Eu-155 NotProvided O.OOE+00 N/A N/A

Cs-134 1.67E-03 3.04E-02 9.03E-04 1.78E-02

Cs-137 1.17E2 2.12E-01 1.12E-02 2.21E-01

Pu-238 9.89E-04 _ 1.80E-02 9.75E-04 1.92E-02

Pu-239 3-53E-04 6.42E-03 3.53E-04 6.96E-03

Pu-241 2.13E-02 3.87E-01 1.95E-02 3.85E-01

Am-241 3.05E-04 5.54E-03 3.04E-04 6.OOE-03

Cm-243 8.IOE-05 1.47E-03 7.75E-05 153E-03

Total 5.50E-02 1.OOE+00 5.07E-02 1.OOE+00

Calculated Scaled Dose

Table 5 lists the scaled dose using the rem per Becquerel values from Table 3 and the nuctide scaling

fractions in Table 4. The total dose equivalent per unit intake for the scaled dose is 4.69E-08 rem per

bq or 1.74 mrem per puCi. Therefore, for a nominal activity of I gCi, the estimated dose would be 1.74

mrem. For a Co-60 particle with an activity of 1 RCi, the estimated dose would be 6.96 mrem.

I I
BCY-HP-0125 Revision 0 I

Page 7 of IS

Table 5. Scaled Dose Based Upon WDB Composite Sample.

Scaled Scaled

Total Total NuclIde Total Total Nucilde (Movlgramnbg) (Remibq) Fraction (Renlbq) [mRqem/Ci

Agk 08m 2.39E+01 3.82E-07 1.03E.02 3.94E-09 1.46E-01

AP-241 O.00E+00 O.OOE+00 6.OOE-03 O.oOE+00 O.0E0+00

C-14 0.00E+00 0.00E+00 3.55E-02 O.OE+00 0.00E+00

Cm-243 O.OOE+00 0.D0Es00 1.53E-03 0.OOE+00 O.OOE+00

Co-60 1.18E+01 1.88E-07 2.36E-02 4.45E-09 1.65E-01

Cs-134 O.OOE+00 O.OOE+00 1.78E-02 0.DOE+00 O.0E0+00

Cs-137 O.OOE+00 0.0012+00 2.21E-01 O.OOE+00 0.OOE+00

Eu-152 8.30E+00 1.33E-07 0 O.OOE+00 0.00E+00

Eu-i 54 1.24E+01 1.99E-07 0 O.OOE+00 O.00E+00

Eu-1 55 1.94E+00 3.11 E-08 0 0.OOE+00 O.OOE+00

Fe-55 1.18E-01 1.88E-09 9.01 E-03 1.70E-11 6.29E-04

H-3 O.OOE+00 O.OOE+00 2.67E-02 O.OOE+00 O.OOE+00

Mn-64 3.58E+00 5.75E-08 2.11 E-03 1.21 E-10 4.48E-03

Nb-94 7.92E+00 1.27E-07 9.07E-03 1.1SE-09 426E-02

tNl-63 4.81E-01 7.39E-09 6.72E-02 4.97E-10 1.84E-02

Pu-238 2.83E+01 4.3E-07 1.92E-02 8.70E-09 3.22E-01

Pu-239 2.61 E+01 4.19E-07 6.96E-03 2.922-09 1.08E201

Pu-241 9.84E-02 1.5E-09 3.85E-01 6.07E-10 2.25E-02

Sr-so 2.90E+01 4.65E-07 3.94E-02 1.83E-08 6.77E-01

Tc-99 3.21 E+00 5.14E-08 1.20E-01 6.17E-09 228E-01

Total 1.57E+02 2.52E-06 1.00E+00 4.69E208 1.74E200

Conclusion

At a nominal activity of 1 ,uCi, composed of a conservative radionuclide mix, an ingested particle would result in a conservative estimated dose of 1.7 mnrern. For ingestion of a 1 giCi Co-60 particle, the CEDE is conservatively estimated as 6.96 mnrem.

I I I
BCY-HP.0125 Revision 0

Page 8 of 18

AlTTACHMENTS

1. ENDOS runs for the shortest and longest half-life nuclides listed in the LTP.

2. Mev/g for Target Organs from Disintegrations in the Small Intestine.

3. Mev/g for Target Organs from Disintegrations in the Upper Large Intestine.

4. Mev/g for Target Organs from Disintegrations in the Lower Large Intestine.

5. Mev/g for Target Organs from Disintegrations in the Stomach.

6. Part 61 Analysis of Waste Disposal Building Composite in 2000.

REFERENCES

1. Internal Commission on Radiological Protection, 1977-1982, Annals of the ICRP, Limits for Intakes

of Radionuclides by Workers, ICRP Publication 30.

2. Connecticut Yankee License Termination Plan. August 2002, Revision 1. pages 5-22 to 5-24.

I_
BCY-HP-0125 Revision 0

Attachment 1

Page 9 of 18

19-DEC-02

RADIATION SAFETY & CONTROL SERVICES, INC.

Shortest Half Life

NUMBER OF DISINTEGRATION TABLE

****************************** RADIONUCLIDE ******************************

Shortest

PHYSICAL HALF-LIFE - 3.120E+002 DAYS

RESPIRATORY AND GI TRACT MODELS *********************

ACUTE INGESTION INTAKE

STANDARD ICRP 30. GI TRACT MODEL USED

FRACTION OF INTAKE DEPOSITED IN STOMACH = 1.000

********************* PARAMETERS FOR SYSTEMIC MODEL ***********f**********

COMPARTMENT COEFFICIENT BIOLOGICAL HALF-LIFE (DAYS)

1 1.OOOE+000 2.200E-006

****************************** INTAKE ************************************

NUMBER OF DISINTEGRATIONS IN REFERENCE MAN CALCULATED

WITH INTAKE OF 1.0 Bq

i --
'BCYHIP-0125 Revision 0

Attachment 1

Page 10 of 18

PAGE 2

**** * PARAMETERS FOR LUNG AND GI TRACT. MODELS *

GI TRACT PARAMETERS

GI TRACT REMOVAL HALF-TIME

REGION (DAYS)

S 2.888E-002

Si 1.155E-001

ULI 3.755E-001

LLI 6.931E-001

i. .....

I I
--- L 

I :~I

BCY-HP.0125 Revision 0

Attachment 1

Pagellof 18

1

4

I PAGE 3

NUCLEAR TRANSFORMATIONS IN BODY RESULTING

FROM A 1.0 Bq INGESTION INTAKE OF Shortest

NUMBER OF TRANSFORMATIONS IN

COMPARTMENTS FROM

0.OOOE+O0O DAYS O.OOOE+000 DAYS

TO TO

COMPARTMENT FIFTY YEARS 2.OOOE+000 DAYS RATIO

SYSTEMIC COMPARTMENT 1

TOTAL SYSTEMIC

STOMACH

SMALL INTESTINE

UPPER LARGE INTESTINE

LOWER LARGE INTESTINE

TOTAL GI TRACT

NASAL PASSAGE -

LUNGS

0.OOOB+OOO

O.OOOE+000

3.600E+003

1.439E+004

4.672E+004

B.607E+004

1.508E+005

O.OOOE+000

O .OOOE+000

O .OOOE+000

O.OOOE+OOO

3.600E+003

1.439E+004

4.491E+004

5.829E+004

1.212E+005

O.OOOB+OOO

O.OOOEiOOO

1.OOOE+000

1.OOOE+000

9.612E-001

6.773E-001

8.038E-001
BCY-HP-0125 RevIslon 0

Attachment 1

Page12of 18

19-DEC-02

RADIATION SAFETY & CONTROL SERVICES, INC.

Longest Half Life

NUMBER OF DISINTEGRATION TABLE

****************************** RADIONUCLIDE ******************************

Longest

PHYSICAL HALF-LIFE 7.770E+007 DAYS

********************* RESPIRATORY AND GI TRACT MODELS *

ACUTE INGESTION INTAKE

STANDARD ICRP 30 GI TRACT MODEL USED

FRACTION OF INTAKE DEPOSITED IN STOMACH = 1.000

********************* PARAMETERS FOR SYSTEMIC MODEL **********************

COMPARTMENT COEFFICIENT BIOLOGICAL HALF-LIFE (DAYS) ______________________________________________________

1 1.OOOE+000 2.200E-006

****************************** INTAKE ***********************************

NUMBER OF DISINTEGRATIONS IN REFERENCE MAN CALCULATED

WITH INTAKE OF 1.0 Pq

I I I
BCY-HP-0125 Revision 0

Attachment I

Page 13 of 18

PAGE 2

1*7 FPARAMETERS FOR LUNG AND GI TRACT MODELS tiVr*********t

GI TRACT PARAMETERS

GI TRACT REMOVAL HALF-TIME

REGION (DAYS) ___________________________________________________________________-

S 2.888E-002

SI 1.155E-OO1l

UI.I 3.75SE-OO1

LLI 6.931E-001

. _

- I_
BCY-HP.0125 Revision 0

Attachment 1

Page 14 of 18

PAGE 3

-NUCLEAR TRANSFORMATIONS IN BODY RESULTING

FROM A 1.0 Bq INGESTION INTAKE OF Longest

NUMBER OF TRANSFORMATIONS IN

COMPARTMENTS FROM ________________________________

O.000E+000 DAYS O.OOOE+000 DAYS

TO TO

COMPARTMENT FIFTY YEARS 2.000E+O00 DAYS RATIO

SYSTEMIC COMPARTMENT 1

TOTAL SYSTEMIC

STOMACH

SMALL INTESTINE

UPPER LARGE INTESTINE

LOWER LARGE INTESTINE

TOTAL GI TRACT

NASAL PASSAGE

LUNGS

0.000E+000

O.OOOE+000

3.600E+003

1.440E+004

4.680E+004

8.640E+004

1.S12E+005

o.OOOE+000

0.000E+000

O.OOOE+000

0.00OE+000

3.600E+003

1.440E+004

4.498E+004

5.844E+004

1.214E+005

0.000E+000

0.OOOE+000

1.000E+000

1.000E+000

9.610E-001

6..763E-001

B.030E-001
BCY-HP-0125 Revlslon 0

Attachment 2

Page 15 of 18

Attachment 2. Mevlg for Target Organs from Disintegrations In the Small Intestine

I1

MeV per UleV per MeV per MeV per leV per MeV per 11eV per MUV per M4eV per MeV per MeV per NoV pu M . eV per MeV per UeV per MeV per

,q,, l b Bone g b VW S1/__ a g l bq bq gIbq Q/bj g/bq g bq g / bq g / bq g / bq g I bg q Lbq g/ bq

Bone

Nuclid Adrenals Surf Btust Gonads Kidneys Uver LU Wall Lunns Pancreas R Marrow St Wall S STWa S IVnmus lhyroid UU wall Uterus

Ag108m 5.94E-03o0.ooEo 1.88E-02 1.868-01 1.49E-02 8.74E433 332E-02 3.14E-03 9.61E-03 2.45E-02 8.38E-01 0.00E+00 0.OOE+00 O.OOE+00 O.OOE+00 1.14E-01 0.00E400

Ar-241 N/A1 NrA NrA NWA N/A N/A N/A NWA NWA NWA NtA NWA NWA NrA NWA NIA N/A

C-4 NJA WA WNA N/A N/A N/A N/A WA N/A NWA NIA NrA NWA NWA WA W/A WA

Cn-24_ NA N/A NWA NA N/WA N/A NIA NWA NA WA NA NWA NWA WA WNA N/A NWA

Co-60 8.21E-03 O.ooE+00 25E-02 2.56E-01 0.00E+00 1.0E-02 4ME-02 4.84E-03 O.00E+00 3.28E-02 3.02E-01 0.002E00 O.00E400 1.21E-03 o.00E+00 1.47E-01 5.53E-02

Cs-134 N/A NWA NWA N/A NA N/A N/A N/A N/A N/A NWA NWA NWA NWA W/A N/A N/A

Cs-137 N/A NA WA WA WA WA WA N/A WA NA N/AJA N/A WAA WNA NIA N/A

Eu-162 3.89-E03 1.382-03 127E-02 1.30E-01 1.04E-02 .0sE5-03 22sE-02 2.25E-03 6.22E203 1.73E-02 2.61E-01 041+00 O.OOE400 0.002+00 0.00E+0017.50E-02 O.OOE+O00

Eu154 4.15E-03 1.43Eo03 o.00E40 1.40oE41 0.OOE+00 848E-03 2.42E-02 2.42E-03 0.001240 1.73E-02 4.23E-01 0.00E+00 0.OOE+00 0.OOE+00 O.OOE+WO 7.I2E-02 o.ooE+00

EuI-155 o.002 1.62-04 0.002+00 1.0812-02 0.002+00 372E-404 1.73E-03 6.91 E.05 0.OOE-100 2.26E-03 0.00r=i00 0.002+00 0.00r24 -0000400 0.00E400 5.88E-03 0.00E4001

Fe-55 i.goE-14 0.002400 1.61E-06 5.042-05 0.00E400 8.8652-08 2.4212-05 7.78E-18 0.OOE-400 1.67E-08 5.18E-03 1.8112-10 0.002+00 0.00E400 '3.OOE-.00 3.89E204 0.002400

3 N/A NWA N/A NWA N/A N/A N/A N/A NWA NWA N/A N/A N/A N/A NWA N/A N/A

Mn-54 2E5-3 9.502-04 2SE-03 9.72E-02 7.60E-03 4.41E403 1 84E-02 1.68E803 4.84E-03 1.1 8E-02 7.69E-02 0.00E+00 0.00E+00 3.72E-04 O.OOE+00 5.36E-02 1.99E-02

Nb-94 ooEoc .+oo OE40 0.001400 9.002-03 O.OOE+OO o.OOE20 3.02E-02 3.11 E-03 o.OEa00 22s2-0 320E-01 0.00E+0 0.00E+00 0.00E+00 0.00E+00 1.04E-01 0.002+00

NI63 .00E+00 0.00E+0o 0.00E+00 0.00E+00 0.00E+00 O.OOE+00 0.00E+00 0.00.E*00 0.00E+00 0.000E+0 1.81E-02 0.00o2o+00 0.00WE+00 .ooE+00 OOE400 0.002E00 Q.OOE+00

PU-238 .E400 O.OOE+W o.wE+oo .002+00 0.002o.o+E+00 .400 O.OOE+00 OOOE400 O.OOE+00 O.OE+00O 0.00 0 0.E+00 0.00E+00 0.00E+00 O.0E2400 0.002+00 0.002+00

Pu-239 O.oE OO.E4o 0.00.+00 0.00W+OO O.0OE+00 0.000E+00 o.0E+00 O.OOE+00 0.OOE+00 0.002400 .OOE00W+00 O.OCE+00 0.02 O00+00 .OOE0 0 0.00240 .OOE+0E

Pu-241 .0024WE00.C 00 0.00.E+DO 0.00E+ O.0E0400 I 0.00240 o.020.0 0.00E400 O.OoE 4 0 W .004E40 Qo 0.004E+00 O.OE+00 O.OOE+00 0.00E+00 0.002400,0.00E+00

Sr-9 .ooE+oo0.00o+00 0.00o+OW 0.00 0.W00.000.0 0200 O.OOE+0 0.0CI+00 O.OOE+ 0.OOE40 .oOE400 0.00E+00 0.00E+4W 0.00E+00 o.o0E04 Q.OOE+00 0.ooE4+0

Tc-99 00.00 3 00 0.00E00 a.00240 0.00400 0.004W 0.00400 I0G.00E0 0.002+00 0.002400 0.00E+00 0.00Not 0nIR 

'Values Not Pro vidled in ICRP 30.

_ _
BCY- P-0125 Reision 0

Attachment 3

Page 16 of 18

Attachment 3. Mevlg for Target Organs from Disintegrations In the Upper Large Intestine

MeV per MeV per MeV per MeY per MeV per MeV per MeV per UleV per leV per MeV per MeY per MeV per MeV per MeV per l4eV per MeV per MeV per

gIbq albq 9 gL jgbq I g/bq ubq g/bq 91bq _ glbg glbq gqibq jbqg 91q glbq g/bq g/b -g/bq

Bone

Nuclid Adrenali Surf Bremast Gonads Kke" Lihvr LU Wall Lungs Pancreas R Marrow Sl Wall sawn ST Wall rhymus Thyroid ULI wall Uterus

Ag108m 1.s7Eg02 .OE4Woo 5.82E-02 7.452-01 4.26E5-02 97-02 .83E-02 1.13E202 2.84E42 8.81E-02 25E-01 a .OOE+0.0040 .O0+00 0.0W02 4.72+00 E.00400

241 wA1 NtA WIA NtA NA IA WA WA /AA A I A WA WA N/A NIA WA WA

C-14 N/A NIA IA NWA NWA NWA N/A N/A WA NWA WA NA N/A N/A N/A NWA N/A

Cm-24 N/A N/A NA NA MA NIA WA WA NA NWA WA WA N/A A N/A NWA- WNA

CO-60 67E-02 0.004W0 8.42E-02 6.08E-01 O.00E+O 5.61E-02 6.74E-02 197E-02 D.OOE+00 8.98E-02 3.37E-01 O.OOE+O O..E+00 4.21E-03 o.OOE+00 1.S4E400 1.092-01

CS-134 N/A WA WA WA NA WA N/A N/A WA N/A N/A N/A WA N/A NWA N/A N/A

Cs-137 N/A N1A WA NIA NIA N/A WA N/A /A WA WA NA WA N/A N/A NWA NWA

Eu-152 1.21E-02 932-03 o3E-02 374E-01 3.09E-02 z6E-02 3.37E-02 &42E-03 2.194-02 4.77E-02 I.71E-01 O.oo00+ 0oo5o+o .00oE400 0.OOE4O 1.35E200 0.00E+00

Eu;154 1.2-02 21E-03 .OOE40 3.86E-01 O.OOE400 Z81E-02 3 9.55E-03 Q.00E+00 4.88E-02 1.BOE-01 .00E400 OOE240 ].00E40 0.OOE+00 2.3100 0.00E+00

Eu.-155 0.00400 .77 4 0 O.OOE+ 3I1E-02 0.00QE40 1.74E-03 Z33E-03 Z8E-04 0.00+00 B.18E-03 Q.OOE+40O .00E+00 0.004+00 Q.WOOE0 0.00+00 4.49E-01 O.OOE00

Fe-55 1.83E-14 .00E+ 522E-07 2.34E-04 .0E400 4.49E-07 7.02E4- 25E-17 OOE40D 3.93E-06 1.54E -05 1.6E-10 0.001+40 0.002E00 0.00o+00 2.78E-02 O.OOE400

H-3 NIA VA WAA NA NTA- NIA N/A NWA NWA tVA N/A WA N/A N/A NIA WA NWA

Mn-54 .2sE-03 82-E03 2.87E-02 2.92E401 2.19-02 1.94E-02 2.50-02 6.17E-03 I.542402 3.14E.02 1 23E-01 .002E00 0.00240 1.322-03 O.DOE+OO 9.65E-01 3.65E-02

Nb-94 O.WE400 .oOE4 Q.OOE+00 3.39E02 O.WE4+O .00E+00 .T7E402 1.12E-02 .00+OO 5.18E-02 233E-01 .OOE+0 .00E+O O.0E+40 0.00E400 1.71E+00 0.00E+00

NI-3 .0WE+OO Q00E2400 .00+00 .00 O.OOE+ OO Q.00Eo00 .00400 E002OO .0 00 .00 4E+00 .00EW0 0020 0E+W0 +0 .00*00 .00E+00 0.002+00 1.09E-01 0.002E+

PU-238 O.WoE+W 1.97E- .E+00O2O 11 E07 o.00o2+00 .05E-0 37205 1.011E-07 J.O0+O0 .14E-05 .00 E00 .002.00 .002400 .0OE400 O.0E+00 7. 40 0.00E+00

Pu-239 .00E+00 1.02E-06 0.002400 8.0727 0.00E+0 372E06 1.43E-05 37E-07 O00O+00 1.57E-05 .00+0 Q +O 0005+0 0.0E40 0.00.+00 .46E+00 0.00E+00

Pu-241 DoE+0 oo.00O+00 .E+020 O.00E+00 .00E+00 .0E2+0 .00E+0W 0.OOE40O .002400 0.00E+00 O002+O0 .0E0400 .002+00 .00+00 0.00E+00 .002+00 0.00E+0o

Sr-9O o.002+o 1.172-09 0 .0020 O.002E+00 o.00E+00 .000 552-0 2.41 E-14 i.002+0 1.97E-08 E.00+00 0.00E+00 0 00 .002400 0.OOE+00 7.132E+0 0.002+00

Tc-99 O.OO200 6..0400 ODOE+W .oo+00 4OOE+O0 .002400 6.0025+00 .002.0 .0E+00 O.OOE+0 E.00400 0.00E+00 0002400 .002+500 O.O0+00 8.42E-01 o.oo0+o0

'Values Not Provided in ICRP 30

I

I

i
BCY-BP-0125 Revision 0

Attachment 4

Page 17 of 18

Attachment 4. Mev/g for Target Organs from Disintegrations in the Lower Large Intestine

MeY pcr MeV per MeV per MeY per MeV per MeV per MeV per MeY per MeY per MeV per MeV per MeV per MeV per MaY per MeV per MeV per MeV per

g~bg - gIbg g I bg gb / bq jjbq 91bq g.b. gibq gibq obq g/bq gIbq 91bq Ubg gbib gibq

Nucilde Adrenals Surt Breast Gonads Kldnevs Uver LU Wall Lungs Pancreas R Marrow SI Wall Spleen ST Wall Thymus Thyrold UU wall Uterus

Aq108m 11.42E-02 O.OOE+00 1.23E-01 2.o012+0o o 46E-02 9.96E-03 1.37E01 .7103 2.16E-02 1.29E-01 2-62E-01 0.OaE4-0 0.0012400 0.00F2.& 0.00E4ZO J.E-01 0.002+00

241 N/A' N/A NIA NWA NWA N/A NWA NIA N/A NWA N/A N/A NWA NWA NWA N/A N/A

C-14 N/A N/A N/A NWA NWA N/A N/A NWA N/A NWA N/A N/A N/A NWA N/A N/A N/A

Crn-24 N/A N/A N/A NWA NtA N/A N/A N/A NWA N/A N/A NWA NIA N/A N/A N/A N/A

Co-60 2.07-02 G.00E400 1.6841 2.81E+00 0.00E+00 1.8142 389E2+00 1.482-02 0o.+OE00 2.38E-01 3.E701 0.00E+00 0.00E+00 3.42E03 0.00E+00 1.71E-01 2.332-01

Cs-134 NVA NVA NWA N/A N/A N/A N/A WA WNA WNA N/A NWA N/A N/A N/A N/A N/A

Cs-137 N/A N/A N/A NVA NA N/A N/A NWA NA NA NA NWA N/A N/A N/A NWA N/A

Eu-152 9.33E2-3 1.O9E02 8.2-02 1.422+00 1.812-02 7.77E003 3.SSE+00 &580E3 1AOE4-02 1.5X-01 1.76E-01 O.0E+00 O.WE002- O.OOE+00 &29E-02 Q.OWE+00

Eu-154 1.04E-02 1.11-02 0.OOE+OO 1.47+00 0.4+00 .29E-03 0.74E+Oo 6.63E-03 QOOE+OO 1.35E-0l 1.87o-01 0.00E+00 0.00E+00 0.00QE+00 00000 &81E-02 0.00Q+0

Eu-155 o.oo0+oo 1.40,-03 o.002+00 1.042-1O O.008-toO 2.28E-04 1.30+E00 1.4E-04 0.00E+00 1.87E-02 Q.OOE+00 0.000+00 0.002E+00 0.OE+00 0.00E+00 570-E03 .OOE+00

Fe-55 1.042-15 0.00WE+OO .81 E-07 .60-04 0.00E+00 1.50E-16 829E-02 2.69E-16 0.00E+00 1.37E-08 124E-05 7.772-12 O. OOE+00 0.00E+00 0.002-tOO 5.18E-05 0S.0E+00

H-3 NtA WA N/A NWA N/A N/A N/A W/A N/A N/A N/A NA N/A N/A WA N/A N/A

Mn-54 7.230-0 7.E2- 6.072-02 9.01 129E-02 5.68E-03 8.27E-01 4.13E-03 1.0-02 8.680-2 .24E-01 O.0E400 0.00+00 1.03E-03 0.00 Q E+ 6.68E-02 7.75E-02

Nb-94 o.002+o0o O.OOE+00 0.00+00 18-01 .00+00 0.00E+00 4.810E00 7.670-03 0.00QE+00 1.S6-01 2.201 0.00o00 0.00E+00 0.00+00 0.0020E 1.09E-01 Q.WE-aCO

Ni-63 o.0E+a0 0.002+0 0.00E+0 o.0o0200 0.0000 0.WE000 3.26E-01 0.E0+00 0.006+00 0.002+00 O.0WE+W00 0.00+00 0.00E+00 0.00E40 0.0+00W O.OE+0 0.00E+00

Pu-238 o.00E+0o 1.4C-E5 o.ooL+oo 7mE-06 oOOE000 7T.7- 2.12+01 4.482 oo0.08 o 2.8-04 O.ooE+00 0.00+00 0.002+00 0.00E+00 0.002400 2.331-04 0.00E+00

Pu-239 O.OOE+OO s.22E-m 0OOE+Wo 1.12E-M 0.00E+00 90E07 1.97E+01 1.76E0 0.004+00 9.ME-05 0.00E+00 0.001+00 0.00E+00 0.00E+00 0.00E400 9.33E-OS 0.00+00

Pu-241 Q.OO+OO 111 E-08 .OOE+00 2.81 E-06 O.OOE+00 7E-0 9.8-02 4.56E49 0.00E+00 3.4-T07 Q0E+0000 0.0+00 O.OOE400 0.002+00 QO 00EE 0.00200 O.OOE+00

Sr.90 0.00E+00 1.01E-0 0.000+0IO.O0E+00 0.00E+00 0.00QO+00 2.1910+01 1.55-15 0.0+0 1 - +0 a +00 000 0.00E0010.000400 21 07 0.OE

Tc-99 0.OOE+0O 0.00E+00 0.00EO0 Q0.00+0 0.00E+00 0.00E+001 1.97E+00 I.002+0 W 2+00 0.00 +0 O0 OOE ooEoo.oo0 - 000 .00240 0W0

'Values Not Provided in ICRP 30 i

i

I

II

0 - .. -T--
BCY-JTP-0125 Revision 0

Attachment 5

Page 18 or 18

Attachment 5. Mev/g for Target Organs from Disintegrations in the Stomach

MeV per MeV per l1eV per MeV per MeV per MeV per MeV per MeV per MeV per MeV per MeV per MeV per MeV per NeV per MeV per MeV per MeV per

g/bq albq 9/bq gtbq bg p /Ibq _glbq 9/bq albq a gg - Ibbq 9/bq b bg a p bgbq g/q I

Done

Nucide AdrenalsB Surf Brast Gonads Kldneys Liver LU Wall Lunags Pancreas arrow Sl Wall Spleen ST Wall Thymus Thyrold UU wall Uterus

Ag108m 2.62E-03 O.OOE+00 4.28E-03 3.82E-03 3.93E-03 2.40E-W M5E-03 4.37E-03 2.08E-02 253E-03 3.061-03 O.OOE+00 O.00E40 0.0017+00 O.OOE+00 3.93E-0 0.0024E0

Arn-241 NWAI NA N/A NWA N/A N/A N/A N/A N/A N/A N/A NWA NWA N/A N/A N/A N/A

C-14 N/A NWA NWA NIA N/A /A N/A NWA N/A WA N/A N/A WA W/A N/A N/A NWA

Cm-243 A NWA NWA NIA WA N/A N/A N/A N/A N/A NA WA NWA N/A N/A NA.- N/A

Co-60 0.00E400 .00E4200 O.OOE,00 0.0OE40 0.0014OOE 0.00E400 0.00E+00 O.OOE+00 0.00E400 0.002+00 O.WEtO4 0.00E4+J0 O.OOE .0 0.00E+00 0.0025+00 0.00E00

Cs-134 W/A WA NWA WA WA W/A NIA NWA N/A WA NWA N/A N/A N/A N/A NWA N/A

Cs-137 NWA N/A WA NIA N/A W/A WA N/A N/A N/A N/A N/A WA N/A N/A WA N/A

Eu-152 WE+OO o0ooE0 o oo0E.0 o.ooE000 O.OE+.0 0.00E4.004 00 O.O .040 0.00EW O OOE+OO O.OOE+OO 0.00E240 O.WE+4O O.OOE+0 0 O.WE400 .OOE 00240 0.004-+00 o.00E40

Eu-154 O.OOE+OO o.0+0w 0+00 0.0020E4 O.OOE4+00 0.000 E+4O 0.0E+00 .0024 0.00E40 O .OO E40W 0.0DE400 0.00E400 0.001400 0.00E+00 0.00WE+00 D.OOE40C

Eu-155 01)0o.0 0.0024 oo~o ooE00 0.002+00 MO0DEM 0.0012+00 0.OOE-iO0 0.002+0 0.002+00 000240( 0.002+400 .0.002440 0.0012400 0.OOE-00 0.0015+00 0.0o..o002 001o7oEWo

Fe-55 o0.0oE00 O.O0E+00 O.0E40 O.OOE40 0.00E400 O.OOE400 0.002+00 0.00E400O0O.0200 0.00200 0.001+00 0.00240 O .OO E40 O.W0E400 0.001400 0.00E+00 0.001400

H-3 WA H/A. WA NWA WA WA N WA NA NA NA MA NA N/A N/A NA N/A

Mn-54 1t7E-03 1.73E-04 Zt11E-03 2.972E03 i.94E-03 1.192-03 7.992-04 2.12-'03 9.4E-03 .21E.03 1ME030 0.004W0 O.OOEW0 3ME. 0.00340WI 1.842-03 5.82E2-

Nb-94 0.00W400 0.002400 O.OOE40 0.00E+00 0.00E400 O.OOEOO O.OOE 0E00 0.002400 0.E+ .002+W0 O E O.OOE+1.00W 0.004 O+ O.W0 0.00E40O 0.00E+00 0.00w+00 0.00E400

NI63 0.00Q4o 0.00E+00 W I00+0oo 0.0E40o0 0OE4W O.O0E4004004 0 .OOE+OO 0.030E+00 .OOE+00 0.00WE4+ 0.00E+00 7.342 0.00E+00 0.W0E+00 0.00W+00 0.00E+00

Pu-238 0l.00E+00 0.0W000 0.00E+o0 0.00E400 0 E400 0.00E+00 0.0040 0.00E4+O OOE+oo O.OOE40 0.00E4O 0.0040 0. 0 .OOE+ooo 0.00E400E 0.oo200 0.00EOO

Pu-239 o.ooE+O o.ooE.oo ooE+ o O.WE+0 o o0o o2.o O.CO+oo o02E4W O.ooE+W .0E+00 0.002400 0.WE400 0.002E+0 0.00E+00 0.00240 O..0E+00 O.WE4W00 0.0024 OOO.WE4W

Pu-241 O.0WE4+ O.0E4W 0.00E4 O.004O00 0.002400 0.00E40 0.00E+00 0.00E4W O.WE400 O.00E+00 0.OOE+00 0.OOE+4O 0.00E4W 0.00E400 0.0012400 0.00.+00 0.00E+W

Sr-90 OOE4W o.o0E+o 0Qw02 O.OOE+o0 0.0024W O .WO4W I 0.002400 0.001+00 0.00o00 O .OOE00+00 0.0WE+00 0.00E+00 O..OO4 0.00WE400 0.0E4W .00 .OOE+00 I

Tc-99 Q.loE0+0o .WE+OO .00E+WOO o.00E4w 0.00E400 O.00E4W0 O.0E4+00 O.OOE40 0o.E+00 0.0W0 0.00oE0 o.ooe+oo 4.32-02 o.ooE400 5.61E-01 0.002+o0 0.OOE+00

t

Values Not Provided in ICRP 30

i